0001193125-22-243917.txt : 20221014 0001193125-22-243917.hdr.sgml : 20221014 20220913193000 ACCESSION NUMBER: 0001193125-22-243917 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc. CENTRAL INDEX KEY: 0001907685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 617.871.2101 EXT 313 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 CORRESP 1 filename1.htm CORRESP

Comera Life Sciences Holdings, Inc.

12 Gill Street, Suite 4650

Woburn, Massachusetts 01801

September 13, 2022

VIA EDGAR

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

  Re:

Comera Life Sciences Holdings, Inc.

Registration Statement on Form S-1

File No. 333-267283

Request for Acceleration

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Comera Life Sciences Holdings, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-267283) so that it may become effective at 4:00 p.m. Eastern time on September 15, 2022, or as soon thereafter as practicable.

[Remainder of this page intentionally left blank]

Very truly yours,
Comera Life Sciences Holdings, Inc.
By:  

/s/ Jeffrey S. Hackman

Name:

   Jeffrey S. Hackman
Title:   Chairman, President and CEO